Non-conventional Techniques of Ventilatory Support

Airway pressure release and biphasic intermittent positive airway pressure ventilation: are they ready for prime time?

Airway pressure release ventilation and biphasic positive airway pressure ventilation are being used increasingly as alternative strategies to conventional assist control ventilation for patients with acute respiratory distress syndrome (ARDS) and acute lung injury. By permitting spontaneous breathing throughout the ventilatory cycle, these modes offer several advantages over conventional strategies to improve the pathophysiology in these patients, including gas exchange, cardiovascular function, and reducing or eliminating the need for heavy sedation and paralysis. Whether these surrogate outcomes will translate into better patient outcomes remains to be determined. The purpose of this review is to summarize the rationale behind the use of these ventilatory strategies in ARDS, the clinical experience with the use of these modes, and their future applications in trauma patients.

Low-Flow Transtracheal Rescue Insufflation of Oxygen After Profound Desaturation

BACKGROUND

The objective of this study was to determine whether low-flow transtracheal insufflation of oxygen (TRIO) could rescue an animal from profound desaturation. This temporizing maneuver could be useful during cannot-intubate or -ventilate scenarios by resolving hypoxia without the morbidity associated with more invasive procedures.

METHODS

Seven swine for a total of 12 runs were studied. Animals were pharmacologically anesthetized, paralyzed, and mechanically ventilated with room air. After disconnection from the ventilator and desaturation to an Spo2 < 50%, low-flow TRIO (2 L/min) was administered for 1 hour.

RESULTS

All animals survived and Spo2 increased to greater than 90% in 23 seconds on average. Pao2 (mean, 183 mm Hg) remained elevated throughout the study. Hemodynamic stability was maintained for at least 15 minutes.

CONCLUSION

Low-flow TRIO rescued animals from profound hypoxia and maintained oxygenation for at least 1 hour. Low-flow TRIO did not prevent hypercarbia with its subsequent sympathetic activation.

Transtracheal oxygen delivery

Tracheal insufflation of oxygen has at least three major uses for chronic oxygen supplementation through a percutaneous catheter, it is an adjunctive measure to enhance gas exchange during mechanical ventilation, and it provides an emergency therapy for oxygen delivery with upper airway obstruction. In this article the mechanisms of gas exchange and techniques of oxygen delivery are described for each of these major uses.

Permissive hypercapnia with high-frequency oscillatory ventilation and one-lung isolation for intraoperative management of lung resection in a patient with multiple bronchopleural fistulae

We report the use of high-frequency oscillatory ventilation in the operating room during repair of multiple bronchopleural fistulae in a 9-year-old boy. In addition, we used principles of permissive hypercapnia to further minimize barotrauma. There were no cardiovascular consequences due to either the high-frequency ventilation or the permissive hypercapnia. Our goals in employing this strategy were to minimize barotrauma, minimize gas flow through the fistulae, and optimize the surgical results.

Acute respiratory distress syndrome

The acute respiratory distress syndrome (ARDS) is a serious and complex clinical problem that often threatens the lives of patients. Emerging clinical data suggest that the survival of patients with this disorder may have improved during the last two decades, presumably because of advances in supportive medical care. Among the supportive therapies used to treat patients with ARDS, none is more complex than mechanical ventilation. New strategies for administering mechanical ventilation to patients with ARDS may reduce the occurrence of iatrogenic volotrauma and oxygen toxicity, accounting in part for the recently observed improvements in patient survival. Prevention and cure of ARDS have remained elusive goals because of the lack of specific therapies directed against the known pathogenic factors. Ongoing investigations are aimed at identifying specific therapies to interrupt the mechanisms of inflammation and lung injury responsible for this syndrome. Until such therapies become available, clinicians caring for patients with ARDS should attempt to minimize additional morbidity and mortality resulting from nosocomial infections and iatrogenic injuries.

The acute respiratory distress syndrome

ARDS is a complex response of the lung to direct (inhalational) and indirect (hematogenous) insults. It is easy to be pessimistic about the benefit of the approaches we have described, but there is evidence that overall survival has improved in recent years. To maintain this progress, new therapies for ARDS must be rigorously evaluated, and their routine use should be recommended only after careful scrutiny of the evidence. Such a course will eliminate the unnecessary risks and costs often associated with unproved therapies.

Acute respiratory distress syndrome ("ARDS"): no more than a severe acute lung injury?

Images